Fig. 4From: Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myelomaPrognostic evaluation of 20-gene signature in patients with newly diagnosed multiple myeloma from GSE24080 (n = 559). a Kaplan–Meier survival curves; b time-dependent operating characteristic curve analysis for survival prediction by using our risk model, EMC92, UAMS70, UAMS17, International Staging System stage (ISS), and RNAseq-based signature in the GSE24080 dataset; c the distribution of 20-gene risk scores; d patients’ survival status and time; e the heatmap of 20 genes expression in patients from the training setBack to article page